Table 2. Change in mean probing depth, periodontal attachment level, and intrabony defect and percentage change in bone fill in alendronate and placebo groups from baseline.
| Clinical parameters | % change from baseline | ALN group | Placebo group | t- value† | p- value |
|---|---|---|---|---|---|
| Mean PD | 2 Month 6 Month | 2.78 ± 1.20 4.16 ± 1.23 | 1.24± 0.83 2.05± 0.94 | 41.01 68.1 | <0.001* <0.001* |
| Mean PAL (mm) | 2 Month 6 Month | 2.38 ± 0.95 3.95 ± 0.88 | 0.97 ± 0.92 1.78 ±1.22 | 41.317 75.789 | <0.001* <0.001* |
| Mean IBD (mm) | 6 Month | 2.10 ± 0.69 | 0.12 ± 0.04 | 302.01 | <0.001* |
| Bone defect fill | 6 Month | 41.05 ±11.40 | 2.5 ± 0.93 | 420.07 | <0.001* |
*Statistically significant at p<0.05
† t test